Skip to main content

Share story

Policy

Warren Calls for AI Antitrust Scrutiny, Deal Review Revamp

Massachusetts Democratic Senator Elizabeth Warren urged Congress on Wednesday to increase antitrust enforcement on emerging technologies such as artificial intelligence and to revamp merger law to require greater public disclosure of information during deal reviews. Speaking in Washington, Warren said corporations do not receive an exemption from antitrust rules simply because they employ algorithms. The comments, reported by Bloomberg on June 24, 2026, focused on the need for updated oversight as companies integrate AI into business practices. Warren called for more transparency in the merger review process without specifying particular legislation or enforcement actions. The remarks align with her prior positions on competition policy but were limited to the AI and deal review topics in this address.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Bloomberg and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.